The Center for Biotechnology & Interdisciplinary Studies at Rensselaer

The Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute interweaves life sciences, physical sciences, and engineering into the fields of biotechnology and medicine, opening exciting new pathways to innovation and discovery. From complex biological networks to nanoscale assemblies that mimic biological processes, CBIS is a powerhouse of academic and research advancement. More than 200 CBIS scientists and engineers are working here to uncover the molecular basis of biological mechanisms and disease, using biological systems as the basis for new therapeutics, and developing new cellular niches critical in tissue regeneration.  more...

Over Ten Years

  • 40 Faculty
  • 200 Ph.D.s Granted
  • 1,000 Undergrads Trained
  • 2,000 Peer-Reviewed Publications
  • 30,000 Citations (ISI)
  • $130MExternal Grant Funding

News & Events

Suicide allows bacteria found in opportunistic infections to create an antibiotic tolerant biofilm, according to a team including researchers at Rensselaer Polytechnic Institute (RPI).

A new method to control the activity of neurons in mice, devised by scientists at Rensselaer Polytechnic Institute (RPI) and Rockefeller University, uses magnetic forces to remotely control the flow of ions into specifically targeted cells. 

Five members of the Rensselaer faculty have been selected for induction into the College of Fellows of the American Institute for Medical and Biological Engineering.

Through its new Cancer Research Group (CARGO), Rensselaer Polytechnic Institute (RPI) is drawing on its trademark interdisciplinary approach to help battle a disease that kills nearly 600,000 Americans per year and affects countless more.

Professor Steven Cramer received a 2016 American Chemical Society award. Cramer is recognized “for contributions to a molecular-level understanding, adsorption isotherm formalisms, and the development of chromatographic bioprocesses for the purification of biopharmaceuticals.”

Our Center

  • 150 PhD Students
  • 50 Postdoctoral Fellows
  • 33 Principal Investigator Laboratories
  • 25 Visiting Research Scientists
  • 218,000 sq ft modern facility
  • 31, 240 sq ft of open research labs
  • 13,009 sq ft of support labs
  • 27,350 sq ft of core facilities
  • 5,830 sq ft conference and seminar space